# Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)

Study · id `cardio:ct-nct04676659` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04676659](<https://clinicaltrials.gov/study/NCT04676659>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04676659

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

## Technical summary

Registry record NCT04676659. Randomized; single masking; primary purpose treatment. Start 2018-05-12 (actual); primary completion 2020-05-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 240 participants (enrolled count; ClinicalTrials.gov record NCT04676659, source copy `cardio:ctgov-nct04676659-2020-12-21`, retrieved 2026-10-26)
- Started: 2018-05-12 (actual) (ClinicalTrials.gov record NCT04676659, source copy `cardio:ctgov-nct04676659-2020-12-21`, retrieved 2026-10-26)
- Primary completion: 2020-05-30 (actual) (ClinicalTrials.gov record NCT04676659, source copy `cardio:ctgov-nct04676659-2020-12-21`, retrieved 2026-10-26)
- Completion: 2020-07-10 (actual) (ClinicalTrials.gov record NCT04676659, source copy `cardio:ctgov-nct04676659-2020-12-21`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04676659, source copy `cardio:ctgov-nct04676659-2020-12-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04676659-2020-12-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
- Condition: Acute Ischemic Stroke
- Intervention (Drug): TNK-tPA
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER
- Collaborator: CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
- Collaborator class: INDUSTRY
- Collaborator: The First Hospital Of Qiqihar
- Collaborator class: UNKNOWN
- Collaborator: Hebei Medical University Third Hospital
- Collaborator class: OTHER
- Collaborator: Yantai Yuhuangding Hospital
- Collaborator class: OTHER
- Collaborator: Fudan University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Jinan University
- Collaborator class: OTHER
- Collaborator: The First Hospital of Jilin University
- Collaborator class: OTHER
- Collaborator: Huashan Hospital
- Collaborator class: OTHER
- Collaborator: West China Hospital
- Collaborator class: OTHER
- Collaborator: Inner Mongolia Baogang Hospital
- Collaborator class: OTHER
- Collaborator: Linyi People's Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Zhengzhou University
- Collaborator class: OTHER
- Collaborator: Baotou Central Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study (`cardio:pubmed-34429364`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 11 registry organizations

## Provenance

Content hash: d21bed12bda28a15d51368431bb97a18547ca363414605d35faec51c6a415c04
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
